Ivy Rx vs T2D.com
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Ivy Rx
Best for mainstream telehealth GLP-1 accessStarting at $175/mo
T2D.com
Best for diabetic GLP-1 accessStarting at $999/mo
Side-by-Side Comparison
| Feature | Ivy Rx | T2D.com |
|---|---|---|
| Overall Score | ✓7.4/10 | 6.1/10 |
| Starting Price | ✓$175/mo | $999/mo |
| Customer Rating | — | — |
| Features | 3 features | ✓7 features |
| States Available | ✓50 | 1 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Ivy Rx
Pros
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
T2D.com
Pros
- ✓Built specifically for type 2 diabetic and pre-diabetic patients
- ✓Integrated service — prescriber, pharmacy, and delivery handled in one flow
- ✓Offers both compounded semaglutide and compounded tirzepatide
- ✓Temperature-controlled home delivery via UPS or FedEx
- ✓Ongoing prescriber monitoring and support included
Cons
- ✗No pricing published on the public website — must register to see costs
- ✗No states list published on the site
- ✗Newer brand with limited independent reviews
- ✗Compounded only — no brand-name Ozempic, Wegovy, or Mounjaro
Our Verdict
Ivy Rx edges out T2D.com with a higher overall score of 7.4/10 and is particularly strong for mainstream telehealth GLP-1 access. T2D.com remains a solid alternative, especially if you're looking for diabetic GLP-1 access.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.